Royal Bank of Canada’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $0 | Buy |
115
+11
| +11% | +$41 | ﹤0.01% | 7751 |
|
|
2025
Q4 | $0 | Sell |
104
-2,429
| -96% | -$8.82K | ﹤0.01% | 7707 |
|
|
2025
Q3 | $9K | Sell |
2,533
-552
| -18% | -$1.42K | ﹤0.01% | 6546 |
|
|
2025
Q2 | $6K | Buy |
3,085
+2,571
| +500% | +$10.5K | ﹤0.01% | 6613 |
|
|
2025
Q1 | $4K | Buy |
514
+156
| +44% | +$2.15K | ﹤0.01% | 6440 |
|
|
2024
Q4 | $8K | Sell |
358
-293
| -45% | -$4.67K | ﹤0.01% | 6420 |
|
|
2024
Q3 | $14K | Buy |
651
+124
| +24% | +$2.59K | ﹤0.01% | 6239 |
|
|
2024
Q2 | $9K | Buy |
527
+432
| +455% | +$14.1K | ﹤0.01% | 6401 |
|
|
2024
Q1 | $4K | Sell |
95
-1,216
| -93% | -$33.8K | ﹤0.01% | 6540 |
|
|
2023
Q4 | $33K | Buy |
1,311
+710
| +118% | +$17.3K | ﹤0.01% | 6158 |
|
|
2023
Q3 | $20K | Buy |
601
+260
| +76% | +$11.3K | ﹤0.01% | 6185 |
|
|
2023
Q2 | $20K | Buy |
+341
| New | +$17.5K | ﹤0.01% | 6226 |
|
|
2022
Q4 | – | Sell |
-3
| Closed | – | – | 7791 |
|
|
2022
Q3 | $0 | Buy |
+3
| New | +$104 | ﹤0.01% | 7935 |
|
|
2021
Q3 | – | Sell |
-69
| Closed | -$13K | – | 7908 |
|
|
2021
Q2 | $13K | Buy |
69
+12
| +21% | +$3.02K | ﹤0.01% | 6781 |
|
|
2021
Q1 | $15K | Buy |
57
+28
| +97% | +$7.36K | ﹤0.01% | 6611 |
|
|
2020
Q4 | $6K | Buy |
29
+28
| +2,800% | +$5.5K | ﹤0.01% | 6601 |
|
|
2020
Q3 | $0 | Buy |
+1
| New | +$240 | ﹤0.01% | 6969 |
|
|
2020
Q2 | – | Sell |
-3
| Closed | -$1K | – | 6948 |
|
|
2020
Q1 | $1K | Sell |
3
-28
| -90% | -$7.95K | ﹤0.01% | 6503 |
|
|
2019
Q4 | $10K | Buy |
31
+22
| +244% | +$7.89K | ﹤0.01% | 6149 |
|
|
2019
Q3 | $3K | Buy |
+9
| New | +$3.56K | ﹤0.01% | 6227 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | – | – | 7162 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | +$424 | ﹤0.01% | 6978 |
|
Other funds holding XFOR
EAM
BCLSI
PA
SVCM
DTC
KCM
VCM
B